The stigma of alcohol-related liver disease and its impact on healthcare
- PMID: 35526787
- DOI: 10.1016/j.jhep.2022.04.026
The stigma of alcohol-related liver disease and its impact on healthcare
Abstract
People with alcohol-related liver disease (ALD) experience stigma and discrimination. This review summarises the evidence on stigma in healthcare and its implications for people with ALD, drawing from the literature on the stigma associated with mental illness and, specifically, alcohol use disorder (AUD). Public stigma, self-stigma and structural stigma all contribute to failure to seek help or delays in seeking help, inferior healthcare, and negative health outcomes, which increase the overall burden of ALD. Stigma can be experienced, but also anticipated and avoided, with both scenarios negatively impacting on ALD healthcare. Blaming people with ALD for their condition is central to the stigma of ALD. Stigma affects ALD healthcare at all stages, from prevention, early detection and intervention, to allocation of scarce resources in liver transplantation. People with lived experience need to be empowered to lead action against the stigmatisation of patients with ALD. Promulgating a dynamic model of individual and social responsibility for AUD, a continuum model of harmful alcohol use, and establishing training on ALD-related stigma for healthcare professionals are strategies to address stigma. Integrating addiction and ALD services, providing stigma-free prevention, and overcoming the frequent separation of addiction services from general healthcare are necessary. Beyond healthcare, addressing social inequality, the social dimensions of ALD risk and outcomes, and ensuring equal access to services is necessary to improve outcomes for all people with ALD. More research is needed on the stigma of ALD in low- and middle-income countries and in countries with restrictive drinking norms. Interventions to reduce the stigma of ALD and facilitate early help-seeking need to be developed and evaluated.
Keywords: cirrhosis; discrimination; inequality; liver; stigma.
Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest GS has received speaker’s honoraria from Lundbeck; AL, JM, JM, MN, CK, SS, PW and PWC report no conflict of interest. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Stigma and care avoidance in people with unhealthy alcohol use: A call for research and action.J Hepatol. 2022 Oct;77(4):1221-1222. doi: 10.1016/j.jhep.2022.06.005. Epub 2022 Jun 15. J Hepatol. 2022. PMID: 35714810 No abstract available.
-
Depiction of alcohol-related liver disease in the EASL International Liver Congress.J Hepatol. 2023 Jan;78(1):e36-e38. doi: 10.1016/j.jhep.2022.08.012. Epub 2022 Aug 19. J Hepatol. 2023. PMID: 35988684 No abstract available.
-
Reply to: "Depiction of alcohol-related liver disease in the EASL International Liver Congress".J Hepatol. 2023 Jan;78(1):e38-e39. doi: 10.1016/j.jhep.2022.10.015. Epub 2022 Oct 31. J Hepatol. 2023. PMID: 36328333 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
